1. Home
  2. OPTN vs SCWO Comparison

OPTN vs SCWO Comparison

Compare OPTN & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPTN
  • SCWO
  • Stock Information
  • Founded
  • OPTN 2010
  • SCWO 2021
  • Country
  • OPTN United States
  • SCWO United States
  • Employees
  • OPTN N/A
  • SCWO N/A
  • Industry
  • OPTN Biotechnology: Pharmaceutical Preparations
  • SCWO Environmental Services
  • Sector
  • OPTN Health Care
  • SCWO Utilities
  • Exchange
  • OPTN Nasdaq
  • SCWO Nasdaq
  • Market Cap
  • OPTN 55.4M
  • SCWO 64.3M
  • IPO Year
  • OPTN 2017
  • SCWO N/A
  • Fundamental
  • Price
  • OPTN $9.14
  • SCWO $0.34
  • Analyst Decision
  • OPTN Hold
  • SCWO
  • Analyst Count
  • OPTN 3
  • SCWO 0
  • Target Price
  • OPTN $9.00
  • SCWO N/A
  • AVG Volume (30 Days)
  • OPTN 166.1K
  • SCWO 312.8K
  • Earning Date
  • OPTN 03-26-2025
  • SCWO 03-27-2025
  • Dividend Yield
  • OPTN N/A
  • SCWO N/A
  • EPS Growth
  • OPTN N/A
  • SCWO N/A
  • EPS
  • OPTN N/A
  • SCWO N/A
  • Revenue
  • OPTN $78,226,000.00
  • SCWO $313,930.00
  • Revenue This Year
  • OPTN $13.42
  • SCWO N/A
  • Revenue Next Year
  • OPTN $38.54
  • SCWO $5,180.00
  • P/E Ratio
  • OPTN N/A
  • SCWO N/A
  • Revenue Growth
  • OPTN 10.20
  • SCWO N/A
  • 52 Week Low
  • OPTN $4.82
  • SCWO $0.30
  • 52 Week High
  • OPTN $22.50
  • SCWO $1.99
  • Technical
  • Relative Strength Index (RSI)
  • OPTN 81.15
  • SCWO 43.07
  • Support Level
  • OPTN $9.12
  • SCWO $0.33
  • Resistance Level
  • OPTN $9.35
  • SCWO $0.43
  • Average True Range (ATR)
  • OPTN 0.25
  • SCWO 0.03
  • MACD
  • OPTN 0.35
  • SCWO 0.01
  • Stochastic Oscillator
  • OPTN 88.99
  • SCWO 10.10

About OPTN OptiNose Inc.

OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.

About SCWO 374Water Inc.

374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The business activities of the company include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.

Share on Social Networks: